Who
John D. Yee
Director
Company insider
Files Form 4 as: Director, Tempest Therapeutics; Director, Comera Life Sciences Holdings.
In numbers
- Trades disclosed
- 3
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 19 May 2022
- Last trade
- 4 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 17 Jun 2026 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 4 Jun 2026filed 17 Jun 2026 | TPST Tempest Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 19 May 2022filed 14 Feb 2023 | Comera Life Sciences Holdingsoption or derivative | SEC FORM 4 Code A | —41,608 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.